HEADER TRANSFERASE 15-JUN-20 6XF0 OBSLTE 06-APR-22 6XF0 7UIR TITLE COCRYSTAL STRUCTURE OF HUMAN CAMKII-ALPHA (CAMK2A)KINASE DOMAIN AND TITLE 2 TIAM1 IN COMPLEX WITH ATP COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT COMPND 3 ALPHA; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: CAMK-II SUBUNIT ALPHA; COMPND 6 EC: 2.7.11.17; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: T-LYMPHOMA INVASION AND METASTASIS-INDUCING PROTEIN 1; COMPND 11 CHAIN: C, D; COMPND 12 SYNONYM: TIAM-1; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CAMK2A, CAMKA, KIAA0968; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 12 ORGANISM_TAXID: 10090 KEYWDS CAMKII, KINASE, HUMAN, CAMK2A, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.OZDEN,M.M.STRATTON,S.C.GARMAN REVDAT 2 06-APR-22 6XF0 1 OBSLTE COMPND SOURCE REMARK REVDAT 2 2 1 HELIX SHEET LINK SITE REVDAT 2 3 1 ATOM REVDAT 1 23-DEC-20 6XF0 0 JRNL AUTH C.OZDEN,M.M.STRATTON,S.C.GARMAN JRNL TITL COCRYSTAL STRUCTURE OF HUMAN CAMKII-ALPHA (CAMK2A)KINASE JRNL TITL 2 DOMAIN AND TIAM1 IN COMPLEX WITH ATP JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 23988 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1251 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.71 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.78 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1554 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.3970 REMARK 3 BIN FREE R VALUE SET COUNT : 89 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4461 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 87 REMARK 3 SOLVENT ATOMS : 35 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.46000 REMARK 3 B22 (A**2) : 2.42000 REMARK 3 B33 (A**2) : -1.97000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.599 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.359 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.362 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.955 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.904 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.836 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4656 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4272 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6326 ; 1.611 ; 1.645 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9883 ; 1.211 ; 1.578 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 561 ; 7.796 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 236 ;35.073 ;21.992 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 756 ;20.590 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;19.314 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 601 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5132 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 974 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 2 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 8 273 B 8 273 7637 0.150 0.050 REMARK 3 2 C 1544 1558 D 1544 1558 304 0.220 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6XF0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1000250074. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : RIGAKU VARIMAX HF REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 R 200K-A REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25278 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.710 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.35400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 2.29400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6VZK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, 16% PEG 6000, 0.1% V/V REMARK 280 TRITON X-114, PH 7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.74600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.48300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 69.41900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.48300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.74600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 69.41900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR B 7 REMARK 465 LYS B 47 REMARK 465 LYS B 48 REMARK 465 LEU B 49 REMARK 465 ARG B 274 REMARK 465 ARG D 1541 REMARK 465 THR D 1542 REMARK 465 LEU D 1543 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 21 CE NZ REMARK 470 LYS A 47 CG CD CE NZ REMARK 470 LYS A 48 CD CE NZ REMARK 470 ARG A 59 CZ NH1 NH2 REMARK 470 GLU A 82 OE1 OE2 REMARK 470 LYS A 148 CE NZ REMARK 470 GLU A 164 CG CD OE1 OE2 REMARK 470 GLN A 167 CD OE1 NE2 REMARK 470 LYS A 223 CE NZ REMARK 470 LYS A 258 CE NZ REMARK 470 LYS B 21 CG CD CE NZ REMARK 470 PHE B 24 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 32 CE NZ REMARK 470 GLN B 55 CG CD OE1 NE2 REMARK 470 LYS B 56 CE NZ REMARK 470 GLU B 58 CG CD OE1 OE2 REMARK 470 LYS B 68 CG CD CE NZ REMARK 470 ARG B 74 CD NE CZ NH1 NH2 REMARK 470 GLU B 81 CD OE1 OE2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 470 LYS B 146 CE NZ REMARK 470 LYS B 187 CG CD CE NZ REMARK 470 LYS B 267 CE NZ REMARK 470 LYS D1554 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 8 -82.82 -41.01 REMARK 500 PHE A 9 -58.53 -29.06 REMARK 500 PHE A 16 -135.45 -126.99 REMARK 500 ALA A 23 -82.04 -62.39 REMARK 500 VAL A 73 108.34 -57.69 REMARK 500 GLU A 82 98.81 -52.74 REMARK 500 GLU A 105 -57.43 73.77 REMARK 500 ASN A 135 38.57 -144.62 REMARK 500 ASP A 156 97.44 55.09 REMARK 500 PHE A 232 77.22 -118.10 REMARK 500 LEU A 252 52.12 -95.27 REMARK 500 SER A 272 51.15 -109.20 REMARK 500 PHE B 9 -45.76 -27.65 REMARK 500 PHE B 16 -137.47 -131.67 REMARK 500 ALA B 23 -124.71 61.89 REMARK 500 ALA B 51 -93.53 -109.49 REMARK 500 VAL B 73 108.23 -56.68 REMARK 500 GLU B 82 -98.99 -32.97 REMARK 500 GLU B 105 -58.97 71.70 REMARK 500 ARG B 134 -2.14 76.29 REMARK 500 ASN B 135 39.96 -145.30 REMARK 500 LYS B 137 149.88 -173.02 REMARK 500 ALA B 150 148.53 -20.06 REMARK 500 ASP B 156 98.66 56.39 REMARK 500 ASP B 215 128.84 -177.63 REMARK 500 LEU B 252 51.05 -94.89 REMARK 500 ASP C1544 33.80 -99.41 REMARK 500 THR D1551 48.67 -109.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR D 1551 GLN D 1552 143.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6XV8 RELATED DB: PDB REMARK 900 6XV8 CONTAINS THE SAME PROTEIN AND PEPTIDE, NO ATP IS PRESENT IN REMARK 900 6XV8 DBREF 6XF0 A 7 274 UNP Q9UQM7 KCC2A_HUMAN 7 274 DBREF 6XF0 B 7 274 UNP Q9UQM7 KCC2A_HUMAN 7 274 DBREF 6XF0 C 1541 1559 UNP Q60610 TIAM1_MOUSE 1541 1559 DBREF 6XF0 D 1541 1559 UNP Q60610 TIAM1_MOUSE 1541 1559 SEQADV 6XF0 ASN A 135 UNP Q9UQM7 ASP 135 ENGINEERED MUTATION SEQADV 6XF0 LYS A 223 UNP Q9UQM7 GLN 223 ENGINEERED MUTATION SEQADV 6XF0 ASN B 135 UNP Q9UQM7 ASP 135 ENGINEERED MUTATION SEQADV 6XF0 LYS B 223 UNP Q9UQM7 GLN 223 ENGINEERED MUTATION SEQRES 1 A 268 THR ARG PHE THR GLU GLU TYR GLN LEU PHE GLU GLU LEU SEQRES 2 A 268 GLY LYS GLY ALA PHE SER VAL VAL ARG ARG CYS VAL LYS SEQRES 3 A 268 VAL LEU ALA GLY GLN GLU TYR ALA ALA LYS ILE ILE ASN SEQRES 4 A 268 THR LYS LYS LEU SER ALA ARG ASP HIS GLN LYS LEU GLU SEQRES 5 A 268 ARG GLU ALA ARG ILE CYS ARG LEU LEU LYS HIS PRO ASN SEQRES 6 A 268 ILE VAL ARG LEU HIS ASP SER ILE SER GLU GLU GLY HIS SEQRES 7 A 268 HIS TYR LEU ILE PHE ASP LEU VAL THR GLY GLY GLU LEU SEQRES 8 A 268 PHE GLU ASP ILE VAL ALA ARG GLU TYR TYR SER GLU ALA SEQRES 9 A 268 ASP ALA SER HIS CYS ILE GLN GLN ILE LEU GLU ALA VAL SEQRES 10 A 268 LEU HIS CYS HIS GLN MET GLY VAL VAL HIS ARG ASN LEU SEQRES 11 A 268 LYS PRO GLU ASN LEU LEU LEU ALA SER LYS LEU LYS GLY SEQRES 12 A 268 ALA ALA VAL LYS LEU ALA ASP PHE GLY LEU ALA ILE GLU SEQRES 13 A 268 VAL GLU GLY GLU GLN GLN ALA TRP PHE GLY PHE ALA GLY SEQRES 14 A 268 THR PRO GLY TYR LEU SER PRO GLU VAL LEU ARG LYS ASP SEQRES 15 A 268 PRO TYR GLY LYS PRO VAL ASP LEU TRP ALA CYS GLY VAL SEQRES 16 A 268 ILE LEU TYR ILE LEU LEU VAL GLY TYR PRO PRO PHE TRP SEQRES 17 A 268 ASP GLU ASP GLN HIS ARG LEU TYR LYS GLN ILE LYS ALA SEQRES 18 A 268 GLY ALA TYR ASP PHE PRO SER PRO GLU TRP ASP THR VAL SEQRES 19 A 268 THR PRO GLU ALA LYS ASP LEU ILE ASN LYS MET LEU THR SEQRES 20 A 268 ILE ASN PRO SER LYS ARG ILE THR ALA ALA GLU ALA LEU SEQRES 21 A 268 LYS HIS PRO TRP ILE SER HIS ARG SEQRES 1 B 268 THR ARG PHE THR GLU GLU TYR GLN LEU PHE GLU GLU LEU SEQRES 2 B 268 GLY LYS GLY ALA PHE SER VAL VAL ARG ARG CYS VAL LYS SEQRES 3 B 268 VAL LEU ALA GLY GLN GLU TYR ALA ALA LYS ILE ILE ASN SEQRES 4 B 268 THR LYS LYS LEU SER ALA ARG ASP HIS GLN LYS LEU GLU SEQRES 5 B 268 ARG GLU ALA ARG ILE CYS ARG LEU LEU LYS HIS PRO ASN SEQRES 6 B 268 ILE VAL ARG LEU HIS ASP SER ILE SER GLU GLU GLY HIS SEQRES 7 B 268 HIS TYR LEU ILE PHE ASP LEU VAL THR GLY GLY GLU LEU SEQRES 8 B 268 PHE GLU ASP ILE VAL ALA ARG GLU TYR TYR SER GLU ALA SEQRES 9 B 268 ASP ALA SER HIS CYS ILE GLN GLN ILE LEU GLU ALA VAL SEQRES 10 B 268 LEU HIS CYS HIS GLN MET GLY VAL VAL HIS ARG ASN LEU SEQRES 11 B 268 LYS PRO GLU ASN LEU LEU LEU ALA SER LYS LEU LYS GLY SEQRES 12 B 268 ALA ALA VAL LYS LEU ALA ASP PHE GLY LEU ALA ILE GLU SEQRES 13 B 268 VAL GLU GLY GLU GLN GLN ALA TRP PHE GLY PHE ALA GLY SEQRES 14 B 268 THR PRO GLY TYR LEU SER PRO GLU VAL LEU ARG LYS ASP SEQRES 15 B 268 PRO TYR GLY LYS PRO VAL ASP LEU TRP ALA CYS GLY VAL SEQRES 16 B 268 ILE LEU TYR ILE LEU LEU VAL GLY TYR PRO PRO PHE TRP SEQRES 17 B 268 ASP GLU ASP GLN HIS ARG LEU TYR LYS GLN ILE LYS ALA SEQRES 18 B 268 GLY ALA TYR ASP PHE PRO SER PRO GLU TRP ASP THR VAL SEQRES 19 B 268 THR PRO GLU ALA LYS ASP LEU ILE ASN LYS MET LEU THR SEQRES 20 B 268 ILE ASN PRO SER LYS ARG ILE THR ALA ALA GLU ALA LEU SEQRES 21 B 268 LYS HIS PRO TRP ILE SER HIS ARG SEQRES 1 C 19 ARG THR LEU ASP SER HIS ALA SER ARG MET THR GLN LEU SEQRES 2 C 19 LYS LYS GLN ALA ALA LEU SEQRES 1 D 19 ARG THR LEU ASP SER HIS ALA SER ARG MET THR GLN LEU SEQRES 2 D 19 LYS LYS GLN ALA ALA LEU HET EDO A 301 4 HET EDO A 302 4 HET MG A 303 1 HET EPE A 304 15 HET ATP A 305 31 HET MG B 301 1 HET ATP B 302 31 HETNAM EDO 1,2-ETHANEDIOL HETNAM MG MAGNESIUM ION HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETSYN EDO ETHYLENE GLYCOL HETSYN EPE HEPES FORMUL 5 EDO 2(C2 H6 O2) FORMUL 7 MG 2(MG 2+) FORMUL 8 EPE C8 H18 N2 O4 S FORMUL 9 ATP 2(C10 H16 N5 O13 P3) FORMUL 12 HOH *35(H2 O) HELIX 1 AA1 ARG A 8 GLU A 11 5 4 HELIX 2 AA2 LYS A 47 LEU A 49 5 3 HELIX 3 AA3 SER A 50 LEU A 66 1 17 HELIX 4 AA4 GLU A 96 GLU A 105 1 10 HELIX 5 AA5 SER A 108 MET A 129 1 22 HELIX 6 AA6 LYS A 137 GLU A 139 5 3 HELIX 7 AA7 THR A 176 LEU A 180 5 5 HELIX 8 AA8 SER A 181 ARG A 186 1 6 HELIX 9 AA9 LYS A 192 GLY A 209 1 18 HELIX 10 AB1 ASP A 217 ALA A 227 1 11 HELIX 11 AB2 THR A 241 LEU A 252 1 12 HELIX 12 AB3 THR A 261 LYS A 267 1 7 HELIX 13 AB4 PHE B 9 GLU B 12 1 4 HELIX 14 AB5 ARG B 52 LEU B 66 1 15 HELIX 15 AB6 LEU B 97 GLU B 105 1 9 HELIX 16 AB7 SER B 108 MET B 129 1 22 HELIX 17 AB8 LYS B 137 GLU B 139 5 3 HELIX 18 AB9 THR B 176 LEU B 180 5 5 HELIX 19 AC1 SER B 181 ARG B 186 1 6 HELIX 20 AC2 LYS B 192 GLY B 209 1 18 HELIX 21 AC3 ASP B 217 ALA B 227 1 11 HELIX 22 AC4 THR B 241 LEU B 252 1 12 HELIX 23 AC5 THR B 261 LYS B 267 1 7 HELIX 24 AC6 SER C 1545 MET C 1550 1 6 HELIX 25 AC7 SER D 1545 MET D 1550 1 6 SHEET 1 AA1 5 TYR A 13 LYS A 21 0 SHEET 2 AA1 5 SER A 25 LYS A 32 -1 O VAL A 27 N LEU A 19 SHEET 3 AA1 5 GLN A 37 ASN A 45 -1 O ILE A 43 N VAL A 26 SHEET 4 AA1 5 HIS A 84 PHE A 89 -1 O PHE A 89 N ALA A 40 SHEET 5 AA1 5 LEU A 75 GLU A 81 -1 N ASP A 77 O ILE A 88 SHEET 1 AA2 2 VAL A 131 VAL A 132 0 SHEET 2 AA2 2 ILE A 161 GLU A 162 -1 O ILE A 161 N VAL A 132 SHEET 1 AA3 2 LEU A 141 LEU A 143 0 SHEET 2 AA3 2 VAL A 152 LEU A 154 -1 O LYS A 153 N LEU A 142 SHEET 1 AA4 5 TYR B 13 LYS B 21 0 SHEET 2 AA4 5 VAL B 26 LYS B 32 -1 O VAL B 27 N LEU B 19 SHEET 3 AA4 5 GLN B 37 ASN B 45 -1 O ILE B 43 N VAL B 26 SHEET 4 AA4 5 HIS B 84 PHE B 89 -1 O PHE B 89 N ALA B 40 SHEET 5 AA4 5 LEU B 75 SER B 80 -1 N ILE B 79 O TYR B 86 SHEET 1 AA5 2 VAL B 131 VAL B 132 0 SHEET 2 AA5 2 ILE B 161 GLU B 162 -1 O ILE B 161 N VAL B 132 SHEET 1 AA6 2 LEU B 141 LEU B 143 0 SHEET 2 AA6 2 VAL B 152 LEU B 154 -1 O LYS B 153 N LEU B 142 LINK MG MG A 303 O1B ATP A 305 1555 1555 2.71 LINK MG MG B 301 O1B ATP B 302 1555 1555 2.39 CISPEP 1 SER A 234 PRO A 235 0 2.78 CISPEP 2 SER B 234 PRO B 235 0 1.49 CRYST1 43.492 138.838 154.966 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022993 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007203 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006453 0.00000